Presbyopia eye drop review
Safety and efficacy of AGN-190584 (Vuity drops) in individuals with presbyopia – the GEMINI 1 phase 3 randomised clinical trial
Dr Trevor Gray4 min read
Advertisement
Safety and efficacy of AGN-190584 (Vuity drops) in individuals with presbyopia – the GEMINI 1 phase 3 randomised clinical trial
Virtual clinics for glaucoma care – patients’ and clinicians’ experiences and perceptions: a qualitative evaluation Gunn J, Marks J, Au L, et al Eye (2022) 36:209-218
This update will answer some of the common questions surrounding herpes zoster ophthalmicus (HZO) and highlight recent research, including several key findings from studies performed in Auckland.
Efficacy, durability, and safety of intravitreal faricimab with extended dosing in patients with DMO
The impact of anticancer drugs on the ocular surface
Safety and efficacy of AGN-190584 in individuals with presbyopia: The Gemini 1 phase 3 randomised clinical trialDr George Waring IV et al
Pilot evaluation for an image-based eyelid lesion management service
Patients not showing up to their scheduled appointments is a significant issue, estimated to cost the New Zealand healthcare system $29 million each year
A common incidental clinical finding among optometrists is ‘narrow angles'. That worryingly thin black space on Van Herick assessment alerts us to dust off our gonioscopy lens and perhaps look for some more benoxinate. Management would be straightforward if all the clinical signs showed an eye in tr
In this review, I discuss three recent papers, adding to the role of minimally invasive glaucoma surgery (MIGS) in the management of glaucoma, particularly with respect to long-term efficacy and safety data.
Ocular melanoma (OM) is the most common cancer in the adult eye. OM affects structures in the eye containing melanocytes: the choroid, ciliary body, iris (collectively called the uvea) and the
